Format

Send to

Choose Destination
Pediatr Infect Dis J. 2012 Nov;31(11):e229-31. doi: 10.1097/INF.0b013e318266bf89.

Adherence to guidelines for respiratory syncytial virus immunoprophylaxis among infants with prematurity or chronic lung disease in three United States counties.

Author information

1
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. kecia.carroll@vanderbilt.edu

Abstract

Among infants with prematurity and/or chronic lung disease for whom respiratory syncytial virus immunoprophylaxis is recommended, we examined adherence in infants enrolled during healthcare visits for acute respiratory illness in 3 U.S. counties from 2001 to 2007. Immunoprophylaxis among infants who met national criteria for prophylaxis increased from 33% to 83% over the 6-year period; 17% (11/65) of infants who received immunoprophylaxis did not meet eligibility criteria.

PMID:
22760537
PMCID:
PMC3773819
DOI:
10.1097/INF.0b013e318266bf89
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center